CNP
52
3
BF.B
57
3
SEE
63
2
KMX
53
4
CMS
57
3
RHI
32
2
EL
40
3
CAT
53
3
GIS
47
4
STZ
40
3
T
68
2
AMT
39
2
VZ
59
2
PRGO
43
4
IRM
52
2
CVS
52
5
GS
68
-11
A
53
2
CSCO
74
7
HAL
43
2
CNP
52
3
BF.B
57
3
SEE
63
2
KMX
53
4
CMS
57
3
RHI
32
2
EL
40
3
CAT
53
3
GIS
47
4
STZ
40
3
T
68
2
AMT
39
2
VZ
59
2
PRGO
43
4
IRM
52
2
CVS
52
5
GS
68
-11
A
53
2
CSCO
74
7
HAL
43
2
Financhill
Back

Collegium Pharmaceutical 10K Form

Sell
47

COLL
Collegium Pharmaceutical

Last Price:
$29.84
Seasonality Move:
-6.71%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-07 10Q COLL/Collegium Pharmaceutical Quarterly
2023-08-03 10Q COLL/Collegium Pharmaceutical Quarterly
2023-05-04 10Q COLL/Collegium Pharmaceutical Quarterly
2022-11-03 10Q COLL/Collegium Pharmaceutical Quarterly
2022-08-04 10Q COLL/Collegium Pharmaceutical Quarterly
2022-05-10 10Q COLL/Collegium Pharmaceutical Quarterly

Receive COLL News And Ratings

See the #1 stock for the next 7 days that we like better than COLL

COLL Financial Statistics

Sales & Book Value

Annual Sales: $631.4M
Cash Flow: $54.6M
Price / Cash Flow: 5.92
Annual Sales: $7.30
Price / Book: 4.14

Profitability

EPS (TTM): 1.22000
Net Income (TTM): $43.9M
Gross Margin: $377.3M
Return on Equity: 19.31%
Return on Assets: 3.09%

Collegium Pharmaceutical Earnings Forecast

Key Collegium Pharmaceutical Financial Ratios

  • The Gross Profit Margin over the past 11 years for COLL is 59.76%.
  • The Selling, General & Administrative Expenses for COLL have been equal to 33.31% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 106.91% of Operating Income.
  • The Net Earning history of COLL is 10.96% of Total Revenues.
  • Per Share Earnings over the last 12 years have been positive in 8 years.

Collegium Pharmaceutical Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: COLL
CUSIP: 19459J
Website: collegiumpharma.com

Debt

Debt-to-Equity Ratio: 3.57
Current Ratio: 1.08
Quick Ratio: 0.88

Price-to-Earnings

Trailing P/E Ratio: 16.25
Forward P/E Ratio: 3.9

COLL Technical Analysis vs Fundamental Analysis

Sell
47
Collegium Pharmaceutical (COLL) is a Sell

Is Collegium Pharmaceutical a Buy or a Sell?